A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.

@article{Riordan2005APC,
  title={A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.},
  author={Hugh D. Riordan and Joseph J. Casciari and M. Julia Gonz{\'a}lez and Neil H. Riordan and Jorge R. Miranda-Massari and Paul R. Taylor and James A. Jackson},
  journal={Puerto Rico health sciences journal},
  year={2005},
  volume={24 4},
  pages={269-76}
}
Case studies suggest that vitamin C, given intravenously at doses of 10-100 grams/day can improve patient well being and in some cases, reduce tumor size. While ascorbate is generally considered safe, clinical data on high intravenous doses is limited. Twenty-four late stage terminal cancer patients were given continuous infusions of 150 to 710 mg/kg/day for up to eight weeks. Blood chemistry and blood count profiles were obtained at roughly one-week intervals while patient health, adverse… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

Similar Papers

Loading similar papers…